(Q28212735)
Statements
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin (English)
0 references
21 September 2004
0 references
110
0 references
12
0 references
1658-63
0 references